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bstract
Adult male rats were exposed to a 6 Gy single dose from a Cs-137 source. The radio-mitigation effect of poly-MVA was evaluated
y daily administration of 2 ml/kg of body weight immediately after irradiation for two weeks. The morphological changes in the
ed blood cells were studied. The osmotic fragility and rheological properties of blood, the alteration in the contents of antioxidant
nzymes (glutathione, catalase and superoxide dismutase) and lipid peroxidation in hepatic cells were determined. The results
howed that exposure to radiation resulted in significant changes in cellular antioxidant enzymes (GSH, catalase and SOD) and a
ecrease in the blood Bingham viscosity, yield stress and aggregation index. Furthermore, it induced a slight increase in the average
smotic fragility of red blood cells accompanied by a decrease in osmotic dispersion, as well as a modification of red blood cell
orphology. It also caused a significant increase (75%) in the lipid peroxidation 1 day after exposure to radiation, which persisted
ntil the 14th day recorded after irradiation. Oral administration of poly-MVA after irradiation reduced the radiation-induced damage,
s seen in the non-significant change in lipid peroxidation compared to the control. It also resulted in improvement in the observed
arameters.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
; Lipideywords: Red blood cells; Gamma radiation; Rheological properties
.  Introduction
Accidental exposure to radiation can arise due to
actors beyond the control of the operating agencies,∗ Corresponding author. Tel.: +20 1090135453.
E-mail address: seham ma@hotmail.com (S.M. El-Marakby).
eer review under responsibility of Taibah University.
ttp://dx.doi.org/10.1016/j.jtusci.2015.06.006
658-3655 © 2015 The Authors. Production and hosting by Elsevier B.V. on 
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). peroxidation; Poly-MVA; Radio-mitigation effects
e.g., human error, system failure, sabotage, earthquake,
cyclone, flood, etc. Incidence of radiological accidents,
whether intentional, e.g., associated with military con-
flict and terrorism, or unintentional, e.g., power plant
disasters such as Chernobyl and Fukushima, could lead
to large-scale radiation exposure to occupational work-
ers, patients and the public. Timely and effective medical
response is a crucial component in reducing radiation
harmful effects and mortality. The management of acci-behalf of Taibah University. This is an open access article under the
dental radiation exposure is relatively complicated due
to uncertainties in dose, duration, and organs involved in
radiation exposure. Treatment of the victim in this case
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requires information and measurements that may take
time to determine the suitable therapeutic strategy for
each case. However, after the event of the radiation acci-
dent, it will be important to provide an agent that would
mitigate the effects of ionizing radiation and can pro-
mote or increase the efficiency of the treatment. Ideally,
this agent would be long lasting and easily administered
(preferably orally) and would possess low toxicity.
Agents that possess radioprotective effects can be
classified into three groups according to their action:
radioprotectors, adaptogens and absorbents. Radiopro-
tectors are constituted mainly of sulfhydryl compounds
and other antioxidants [1]. They act as free radical
scavengers that interact with aqueous free radicals or
radicals of bio-molecules by donating hydrogen atoms
to repair the radical species, thus preventing damage.
Adaptogens are substances that can act as stimula-
tors of radio-resistance and offer chemical protection
under low levels of ionizing radiation. They include
novel immuno-modulators (an agent that augments or
diminishes immune responses) and cytokines (number
of substances that are secreted by specific cells of the
immune system, which carry signals locally between
cells, and regulate various inflammatory responses).
Some immuno-modulators are well-tolerated and reduce
susceptibility to infectious agents, as well as reduce rates
of neoplastic transformation. In recent years, radiopro-
tective agents with a novel mode of action have been
investigated, in particular, compounds that can affect
haematopoietic stem cell regeneration to stimulate the
function and regeneration of a stem cell population that
has decreased due to radiation induced damage [2].
Absorbents are substances that can protect organisms
from internal radiation and chemicals, such as drugs that
prevent the incorporation of radioiodine by the thyroid
gland and the absorption of radionuclides 137Cs, 90Sr,
239Pu, etc. [3].
According to the administration time, the radiopro-
tective agents have been classified into three categories:
prophylactic, mitigators, and therapeutic agents [4].
Prophylactic agents are administered before radiation
exposure to prevent radiation damage. A mitigator desig-
nates an agent that is administered during or immediately
after radiation exposure with the aim of preventing
or reducing the action of radiation on tissues before
the appearance of symptoms. It is expected to regulate
the downstream patho-physiological events of radiation
injury. It should act on the radiation injury cascade
and thereby prevent the development of further injury.
Therapeutic agents are given after the development
of clinical symptoms of radiation exposure [5]. Most
radio-prophylactic agents are free radical scavengers,iversity for Science 10 (2016) 251–265
anti-oxidants, cytokines, thiols, and steroids [6,7]. They
can be classified as radioprotectors and/or adaptogens.
Therapeutic agents include suppressors of the renin-
angiotensin system and chronic oxidative stress as well
as agents such as pentoxifylline to treat radiation fibrosis
and growth factors to facilitate recovery from haemato-
logical injury [8]. Most radio-protecting agents, whether
applied clinically or under research study, are either
for prophylaxis or treatment purposes. There are hardly
few radio-mitigating agents. However, all radioprotec-
tive agents (antioxidants, adaptogens or absorbents) can
represent suitable candidates to test their mitigating
effects.
Palladium--lipoic acid is a complex formulated to
act as a non-toxic chemotherapeutic agent for oral
administration. It exists in a prescription version called
DNA Reductase and is available commercially as a
dietary supplement called poly-MVA [9]. The active
ingredient in this complex is the palladium--lipoic acid
polymer, which exists as a trimer of palladium-lipoic
acid joined to thiamine in an arrangement that allows it
to be both water and lipid soluble. The initials “MVA”
stand for minerals, vitamins, and amino acids [10]. Pal-
ladium, as a transition metal, serves as a highly efficient
aerobic catalyst [11]. Toxicological studies indicated that
the LD50 of poly-MVA exceeded 5000 mg/kg, and no
mutagenic effect of the combination was observed in the
Ames test [12]. In a few recent studies, it showed signif-
icant radio-protective and mitigation effects [13–16]. It
significantly reduced the -radiation-induced mortality
in mice and aided recovery from the radiation-induced
loss of body weight after 8 Gy exposures. Additionally,
the radiation-induced DNA damage in these cells was
reduced when poly-MVA was administered to animals
exposed to a lethal dose of 8 Gy whole-body -radiation
[14]. Its administration, for seven days prior to whole
body gamma radiation, significantly reduced the damage
to cellular DNA in bone marrow and blood leukocytes
and prevented the radiation-induced decrease of tissue
antioxidant levels [13]. Administration of poly-MVA for
14 days before exposure to 6 Gy gamma radiation, from
a Cs-137 source, resulted in normal blood viscosity and
yield stress compared to a control group 14 days after
exposure, reducing the damage induced by radiation
exposure. It also resulted in the normal mean osmotic
fragility of red blood cells and reduced lipid peroxidation
[15].
The mitigation effect of poly-MVA was tested in a
previous work, and the results showed that the admin-
istration of poly-MVA for two weeks after whole-body
exposure to 6 Gy gamma radiation alleviates the changes
in dielectric properties of red blood cells [16]. In the
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Table 1
Composition of poly-MVA.
Palladium--lipoic acid complex (1:1) 3.72 × 10−2 mmol/L
Thiamine 2.17 × 10−3 mmol/L
N-acetyl cysteine 1.13 × 10−3 mmol/L
Riboflavin 4.62 × 10−4 mmol/L
N-formyl methionine 1.46 × 10−4 mmol/L
Cyanocobalamin (vitamin B12) 1.37 × 10−4 mmol/L
Rhodium 1.34 × 10−4 mmol/L
Molybdenum 4.63 × 10−4 mmol/L
Ruthenium 1.42 × 10−5 mmol/L
Sodium chloride 2.64 × 10−1 mmol/L
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wata supplied by manufacturer of POLY-MVA, El-Gen LLC, 7 Shirley
treet, Bohemia, NY 11716-1735, USA [57].
resent work, the study of the mitigation effect of poly-
VA on the rheological properties of blood after whole
ody exposure to gamma radiation was carried out.
.  Materials  and  methods
.1.  Chemicals
Poly-MVA is a liquid dietary supplement that con-
ains 23.5 mg/ml of lipoic acid-palladium complex, as
ell as minerals (molybdenum, rhodium and ruthe-
ium), vitamins (B1, B2 and B12), and amino acids
N-acetyl cysteine and formyl methionine), as shown in
able 1.
Poly-MVA, used in this study, was obtained as a gift
rom Garnett McKeen Laboratory, Inc., USA. The active
ngredient of poly-MVA is palladium -lipoic acid com-
lex. It presents a three-dimensional structure, with the
alladium in the centre of the complex, covalently coor-
inated with both the oxygen of the lipoic acid carbonyl
nd the two sulphurs of the thiolane ring and the carboxyl
f the pentanoic chain in a 1:1 ratio [10,17,18].
.2.  Animals
Adult male Swiss Albino rats weighing 200 g were
sed. They were divided into four groups of 18 animals
ach: the control group, treated group with poly-MVA,
rradiated group and treated-irradiated group. Rats were
ept under standard conditions along the experimental
eriod. Food and water were supplied daily ad libi-
um. All animals were housed according to the ethical
ules in compliance with institutional guidelines. The
onditions were the same for all animals throughout
he study. The animals were housed in standard cages
26 cm ×  42 cm ×  15 cm) with sawdust, at constant room
emperature (25 ±  1 ◦C) and relative humidity (45–55%)
ith a 12 h light/dark cycle. They were dissected at threeversity for Science 10 (2016) 251–265 253
time intervals: 1, 7 and 14 days after exposure to radia-
tion.
2.3.  Irradiation
Animals were placed in a specially designed, well-
ventilated, acrylic pie cage, which holds up to 20 rats.
The whole body of the animals was exposed to 6 Gy
gamma radiation from a biological irradiator gamma
cell-40, cesium-137 source with a dose rate: 0.769 cGy/s
(manufactured at the atomic energy agency, Canada) at
the National Center for Radiation Research and Technol-
ogy, Cairo. The dose rate was calibrated at the beginning
of the experimental work by the Egyptian High-Dose
Reference Laboratory.
2.4.  Treatment
Poly-MVA was taken orally with a daily dose of
2 ml/kg of body weight. The rats were divided into three
main groups:
1. Normal control group: the 18 rats were divided into
three subgroups of six rats each and kept un-irradiated
and un-treated as a normal control group. They were
dissected at the same time intervals as the irradiated
groups.
2. Irradiated group: it included three subgroups accord-
ing to the dissection time: 1, 7 and 14 days after
irradiation. Each irradiated subgroup of rats was com-
posed of six rats.
3. Positive control group: poly-MVA was taken daily for
two consecutive weeks. The rats were dissected after
three intervals: 1, 7 and 14 days during administra-
tion.
4. The radio-mitigating effect of poly-MVA was exam-
ined by daily administration of poly-MVA after
irradiation for two consecutive weeks. The animals
were dissected at 1, 7 and 14 days after irradiation,
with the concomitant administration of poly-MVA.
2.5.  Preparation  of  samples
Animals were anesthetized by exposure to diethyl
ether in a closed container using the open-drop method.
The blood samples were withdrawn from the left ven-
tricle of the heart using heparinized needles. After
dissection, the liver was washed with isotonic buffered
NaCl. 10% of liver samples were homogenized in saline
using a Tri-R STIR-R model K41 homogenizer, and
then the homogenate was centrifuged at 3000 rpm for
bah Un254 S.M. El-Marakby et al. / Journal of Tai
10 min at 4 ◦C. The supernatant was separated for use in
analysis.
2.6.  Biochemical  assays
Malondialdehyde concentration (MDA), catalase
activity (CAT), superoxide dismutase activity (SOD) and
glutathione concentration (GSH) were measured in the
liver homogenate. MDA was measured by using a thio-
barbituric acid assay according to the method of Ohkawa
et al. [19]. The obtained results were shown as nmol
of malondialdehyde/g of tissue. GSH concentration was
measured according to the method of Beutler [20]. It was
calculated as g/g of tissue. CAT activity was measured
by catalytic reduction of hydrogen peroxide using the
method of Sinha [21]. It was expressed in terms of units
of catalase activity that consume 1 mol of H2O2/min/g
of tissue. SOD activity was measured by using the
method of Minami and Yoshikawa [22], in unit/g of tis-
sue. One unit of SOD activity is defined as 50% of the
inhibitory level of the enzyme in 1 min per gram tissue
under the assay condition.
2.7.  Haematological  analysis
The haemoglobin concentration (Hb) was evalu-
ated using Drabkin’s reagent and the haemoglobin
standard, which were obtained from EAGLE Diag-
nostics, USA. The principle of the method involves
the oxidation of oxyhaemoglobin, by ferricyanide,
to methaemoglobin, and then cyanide converts
methaemoglobin to cyanomethaemoglobin [23]. The
absorbance of the solutions was recorded at 540 nm,
and the concentration of haemoglobin was obtained
from the comparison of the value of the absorbance to
the calibration curve of the standard haemoglobin.
The determination of the haematocrit (Hct) was per-
formed as follows: blood samples, in a haematocrit
microcapillary tube (75 mm/75 l), were centrifuged for
5 min at 11,500 rpm. Then, the haematocrit values were
determined by means of a microcapillary tube reader.
The mean corpuscular volume (MCV), in femto-
litres, expresses the average size of the red blood cells
(RBCs). It is related to the haematocrit (Hct) by the
following relation:
MCV = Hct =  (fl)
RBCs count (million per litre)
The mean corpuscular haemoglobin concentration
(MCHC), in mg/ml, is a measure of the concentrationiversity for Science 10 (2016) 251–265
of haemoglobin in a given volume of packed RBCs. It
can be calculated as follows:
MCHC = Hb concentration (mg/ml)
Hct
=  (mg/ml)
2.8.  Normal  red  blood  cell  haemolysis
Normal red blood cells (RBCs) haemolysis was deter-
mined by measurement of the haemoglobin released
from the cells relative to the total cellular haemoglobin
content. Ten microlitres of whole fresh blood was
incubated in 5 ml of normal saline for 30 min. The sam-
ples were centrifuged at 3000 rpm for 10 min, and the
absorbance of the supernatant was measured spectropho-
tometrically at 540 nm. The percentage of haemolysis
was taken against complete blood haemolysis in distilled
water [24].
%H  = Asample
A100% lysis
×  100
2.9.  Rheological  properties  of  blood
The rheological properties were measured by means
of a Brookfield DV-III Programmable Rheometer. It is
a cone-plate viscometer that measures the fluid param-
eters of shear stress and viscosity at given shear rates.
The body temperature varies from 29 ◦C at the surface
to 37 ◦C in the blood stream. RBCs’ properties are well
known to be temperature-dependent; thus, statistically
significant differences were present in a wider range
of temperatures between 25–37 ◦C [25]. In this study,
the temperature was set at 35 ◦C. The applied shear rate
ranged from 7.5 to 375 s−1. The data were collected from
the rheometer using the software program “Rheocalc for
Windows”.
2.10.  Osmotic  fragility  measurements
The process of osmosis was studied by placing the
red blood cells (RBCs) in solutions of different tonic-
ity. The osmotic lysis of RBCs can be detected by
the release of haemoglobin (Hb) into the extracellular
fluid. The amount of Hb appearing in media of different
ionic strength was determined spectrophotometrically at
540 nm to characterize the degree of haemolysis accord-
ing to the method reported by Dacie and Lewis [23].
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.11.  Morphological  analysis
The morphology of RBCs was studied using a scan-
ing electron microscope (SEM) according to Ross et al.
26] as follows: three drops of RBCs’ suspension were
dded directly to 5 ml of 2.5% glutaraldehyde in 0.1 M
acodylate buffer (pH 7.4). Fixation was allowed to pro-
eed for at least 24 h before processing. The cells were
ashed twice in cacodylate buffer, dehydrated with two
ashes in 70% ethanol, washed twice in 95% ethanol,
wice in absolute ethanol and twice in acetone. One
rop of the cell suspension was applied to an acetone-
ashed coverslip and allowed to dry. The cover slip
as fixed to an aluminium stub using a colloidal sil-
er adhesive and gold coated using a sputter coater
SPI). Electron microscopy was carried out using a Jeol
odel JSM-5400 scanning electron microscope at the
ational Center for Radiation Research and Technology
NCRRT).
.12.  Statistical  analysis
In this study, the values are expressed as the mean
alues ±  standard deviation. The significance of the dif-
erences between the values of the treated groups and
he control and of the irradiated groups was evaluated
y using the Student t-test; values with p < 0.05 were
onsidered as statistically significant [27].
.  Results
.1.  Biochemical  assays
The concentration of MDA increased significantly
fter the 1st day of exposure to radiation by 75.57%
p = 0.001) above the control and continued to increase
p to the 14th day, reaching 84.11% (p  = 0.008). The
esponse of the three considered antioxidant enzymes
n this study differed as a result of exposure to radiation.
he concentration of the GSH decreased significantly,
rom the 1st day after exposure by 8.43% (p  = 0.011) of
he control value until the 14th day, reaching 11.97%
f the control (p  = 0.001). SOD decreased significantly
p = 0.257 ×  10−2), after 1 day of exposure, by 19.44%
f the control value and continued to decrease rapidly
ntil the 14th day, reaching 76.93% (p  = 0.891 × 10−8).
eanwhile, the CAT exhibited a different trend, as it
howed a significant increase of 36.51% (p  = 0.0094)
f the control after 1 day of exposure to radiation and
eached 17.74% (p  = 0.0214) by the 14th day (Fig. 1).
Poly-MVA resulted in non-significant changes in the
oncentration of MDA from the 1st to the 14th days afterversity for Science 10 (2016) 251–265 255
administration compared to the control group (p  = 0.156,
0.347 and 0.247). CAT and SOD exhibited significant
increases from the control in the overall period of admin-
istration of approximately 70% (p  = 0.848 ×  10−3) and
55% (p  = 1.22 ×  10−4), respectively, while GSH did
not show significant changes during the same period
(p = 0.284, 0.292 and 0.092 at 1st, 7th and 14th days,
respectively) (Fig. 1).
Comparing the effect of poly-MVA after the exposure
to 6 Gy of the irradiated groups showed that:
a) It resulted in a significant decrease in the MDA con-
centration of 34.5% (p  = 0.007) after the 1st day of
exposure and reached 40.8% (p  = 0.009) on the 14th
day after exposure.
b) The GSH concentration showed a gradual increase
from 0.93% (p  = 0.427), after the 1st day of exposure,
to 10.85% (p  = 0.012) and 16.0% (p  = 0.004), at the
7th and 14th day, respectively.
c) The CAT increased significantly after 1 day of radi-
ation exposure by 28.08% (p  = 0.027), persisting to
the 14th day (p  = 0.008) with the same ratio.
d) The SOD increased significantly by 37.7%
(p = 0.0188) after the 1st day and increased highly
significantly by 187.9% (p  = 0.056 ×  10−2) and
561.6% (p  = 0.117 ×  10−4) at the 7th and the 14th
day, respectively (Fig. 1).
Comparing the effect of poly-MVA after the exposure
to 6 Gy of the control group showed that:
a) The MDA concentration increased after the 1st day of
exposure by 14.99% (p  = 0.204), while it decreased
to 12.74% (p  = 0.056) and 8.98% (p  = 0.229) by the
7th and 14th day, respectively.
b) The GSH concentration showed non-significant
changes (p  = 0.058, 0.278 and 0.329 on the 1st, 7th
and the 14th days, respectively).
c) The CAT increased significantly, after 1 day of radi-
ation exposure, by 77.5% (p  = 0.0003) and decreased
to 49.85% (p  = 0.039) and 51.3% (p  = 0.417 × 10−3)
by the 7th and 14th day.
d) The SOD increased non-significantly by 10.94%
(p = 0.187) after the 1st day and increased highly sig-
nificantly by 58.81% (p  = 0.131 × 10−2) and 52.65%
(p = 0.699 ×  10−3) at the 7th and 14th days, respec-
tively (Fig. 1).3.2.  Haematological  analysis
The exposure to 6 Gy resulted in significant decrease,
compared to the control group, in the haemoglobin
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, catala
 days.Fig. 1. The malondialdehyde concentration (MDA), glutathione (GSH)
irradiated and treated-irradiated groups at time intervals of 1, 7 and 14
concentration, starting with an 8.9% (p  = 0.448 ×  10−3)
decrease after the 1st day and continuing to 24.9%
(p = 0.018) and 47.3% (p  = 1.43 ×  10−10) at the 7th
and 14th days, respectively. The haematocrit showed a
significant decrease from the control group of 7.78%
(p = 0.011) after the 1st day and continued to decrease to
13.42% (p  = 2.93 ×  10−4) and 42.14% (p  = 3.18 ×  10−8)
at the 7th and 14th days, respectively. The MCV increased
significantly by 15.46% (p  = 0.302 ×  10−2) after the 1st
day compared to the control group, then by 9.79%
(p = 0.018) and 7.06% (p  = 0.037) at the 7th and 14th days,
respectively. The MCHC exhibited a significant decrease
from the control group of 4.7% (p  = 0.004) after the first
day and continued to decrease to 6.4% (p  = 0.002) and
7.85% (p  = 0.032) after the 7th and 14th days, respec-
tively (Fig. 2). The administration of poly-MVA resulted
in non-significant changes in the haematological param-
eters, except the haematocrit value, which showed a
significant decrease of 10.26% (p  = 0.003) at the 14th
day of treatment (Fig. 2).The treatment with poly-MVA after exposure to 6 Gy
did not show significant changes in the haemoglobin con-
centration at the 1st day after exposure compared to these (CAT) and superoxide dismutase (SOD) enzymes in control, treated,
irradiated group (p  = 0.466), while it increased signifi-
cantly by 12.9% (p  = 0.004) and 73.2% (p  = 0.35 ×  10−3)
at the 7th and 14th days after exposure. However,
this increase in the haemoglobin concentration was
significantly lower than the control group, by approx-
imately 9% (p  = 0.061, 0.020 and 0.029) all over the
considered period. The haematocrit value exhibited
an increase from the irradiated group of 1.6% at the
1st and 7th days (p  = 0.325 and 0.352), and then it
showed a significant increase at the 14th day of 48.44%
(p = 0.788 ×  10−7). Meanwhile, these values were
9.25% (p  = 0.208 × 10−3), 14.78% (p  = 0.134 ×  10−2)
and 14.11% (p  = 0.2236 ×  10−2) below the control val-
ues at the 1st, 7th and 14th days after exposure,
respectively. The mean corpuscular volume and mean
corpuscular haemoglobin concentration showed non-
significant changes from the control group all over
the experimental period. Compared to the irradiated
group, the mean corpuscular volume showed a signif-
icant decrease of 16.65% (p  = 0.777 ×  10−3), 11.34%
(p = 0.933 ×  10−3) and 11.5% (p  = 0.0123) at the 1st,
7th and 14th days, respectively, after exposure. The
mean corpuscular haemoglobin concentration increased
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F corpuscular volume (MCV) and mean corpuscular haemoglobin concentration
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cig. 2. The haemoglobin concentration (Hb), haematocrit (Hct), mean 
MCHC) for control, treated, irradiated and treated-irradiated groups a
y 7.32% (p  = 0.0443), 7.87% (p  = 0.378 ×  10−2) and
4.13% (p  = 0.53 ×  10−2) at the 1st, 7th and 14th days,
espectively, after exposure (Fig. 2).
.3.  Normal  haemolysis
The exposure to 6 Gy gamma radiation resulted in
n increase in the RBCs’ normal haemolysis of 23.99%
p = 0.546 ×  10−3) at the 1st day after exposure that
ontinued to increase to 113.86% (p  = 2.26 ×  10−4) and
98.9% (p  = 0.0084) at the 7th and 14th days after expo-
ure, respectively, as shown in Fig. 3.
The administration of poly-MVA resulted in non-
ignificant changes in the normal haemolysis compared
o the control group (p  = 0.156, 0.347 and 0.247 at the 1st,
th and 14th days after radiation exposure, respectively)
Fig. 3).
The treatment with poly-MVA after exposure to
adiation decreased the normal haemolysis by 23.6%
p = 0.0462) at the 1st day, compared to the irradi-
ted group, and continued to decrease, reaching 61.5%
−3 −2p = 0.2139 ×  10 ) and 67.07% (p  = 0.8298 × 10 ) at
he 7th and 14th days after radiation exposure, respec-
ively (Fig. 3). These values showed non-significant
hanges from the control groups (p  = 0.204, 0.056 andFig. 3. Normal haemolysis of control, treated, irradiated and treated-
irradiated groups at time intervals of 1, 7 and 14 days.
0.229 at the 1st, 7th and 14th days after radiation exposure,
respectively).
3.4.  Osmotic  fragilityOsmotic fragility can be defined as the sensitivity to
change in the osmotic pressure characteristic of red blood
cells. It is considered to be a function of the osmotic
pressure gradient between intra- and extracellular media,
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Fig. 5. Average osmotic haemolysis of control, treated, irradiated and
treated-irradiated groups at time intervals of 1, 7 and 14 days.NaCl conce ntration  (g/l)
Fig. 4. Fragility curve of RBCs.
initial surface area to volume ratio, membrane tension
of haemolysis and ionic content of the cell [28]. It has
been found to be altered in various pathological condi-
tions, such as liver and blood diseases. Thus, the osmotic
fragility test was considered as a potential marker for
oxidative stress [29].
The quantitative measurements (degree of haemol-
ysis versus decreasing NaCl concentration) are plotted
on a graph called the fragility curve, as shown in Fig. 4
[30]. The experimental curves were normalized to 100%
haemolysis to facilitate the comparison between differ-
ent samples without the interference of the haematocrit
changes. The fragility curve can be evaluated by the
following parameters:
1. Average osmotic fragility (H50): the NaCl concen-
tration producing 50% homolysis. The shift of the
fragility curve towards a lower NaCl concentration
indicates a decrease in the average osmotic fragility
and vice versa.
2. Dispersion of haemolysis (S): defined as the differ-
ence between the maximum and minimum values of
NaCl concentration, at which the rate of haemolysis
(dH/dC) = 0. High values of S  correspond to iso-
haemolysis (homogenous RBC population), and low
values of S to anisohaemolysis (heterogeneous RBC
population) [31].
The exposure to 6 Gy gamma radiation resulted in a
non-significant increase in the average osmotic fragility
from the control group (p  = 0.13, 0.17 and 0.06), while
the dispersion of haemolysis showed a non-significant
change at the 1st (p  = 0.13) and 7th (p  = 0.29) days after
exposure and then increased significantly by 20.76%
(p = 0.001) at the 14th day (Figs. 5 and 6).
The administration of poly-MVA showed a non-
significant decrease from the control in the averageFig. 6. Dispersion of haemolysis of control, treated, irradiated and
treated-irradiated groups at time intervals of 1, 7 and 14 days.
osmotic fragility at the 1st day (p  = 0.13), which changed
to a significant increase at the 7th (p  = 0.175 ×  10−3) and
14th (p  = 0.0132) day (Fig. 5). Meanwhile, the dispersion
of haemolysis showed non-significant changes all over
the period of administration (p  = 0.26, 0.08 and 0.44)
(Fig. 6).
The treatment with poly-MVA after irradiation
resulted in a non-significant change from the control in
the average osmotic fragility (p  = 0.17, 0.26 and 0.48),
while the dispersion of haemolysis increased signifi-
cantly by 18% (p  = 0.03, 0.0047 and 0.03) all over the
period of administration (Figs. 5 and 6).
3.5.  Rheological  analysisThe change in viscosity with shear rate gives the flow
curve (Fig. 7), which is characterized by two regions:
the low shear rate region (up to 100 s−1) and high shear
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Fig. 9. Bingham plastic viscosity of control, treated, irradiated and
treated-irradiated groups at time intervals of 1, 7 and 14 days.Fig. 8. Bingham plastic fit for normal RBCs.
egion (from 100 s−1 up to the shear rate at which no
hange in viscosity is obtained).
For analysis of the flow curve, the Bingham plastic
odel (Fig. 8) was applied to calculate the yield stress
Fo) and viscosity (η) as follows:
 =  Fo +  ηD
here F  is the shear stress (dyne/cm2) and D  is the shear
ate (s−1).
Because the blood viscosity at low shear rate is
reatly affected by the RBCs’ aggregation, the ratio of
iscosities at 20 and 100 s−1 can be regarded as quanti-
ative characteristics of the RBC aggregation efficiency
Aggregation index) [32].
Aggregation index = ηat 20 s−1
η −1at 100 s
The exposure to 6 Gy resulted in a significant decrease
n the Bingham viscosity of 9.02% (p  = 0.059 and 0.031)
fter 1 and 7 days and reached 24.5% (p  = 0.001) atFig. 10. The yield stress of control, treated, irradiated and treated-
irradiated groups at time intervals of 1, 7 and 14 days.
the 14th day (Fig. 9). The yield stress showed a signif-
icant decrease from the control of 16.97% (p  = 0.032),
32.96% (p  = 0.048) and 61.4% (p  = 0.334 ×  10−4) at the
1st, 7th and 14th days after exposure, respectively, as
shown in Fig. 10. The aggregation index decreased by
3.5% (p  = 0.148) at the 1st day and continued to decrease,
reaching 9.8% (p  = 0.037) and 28.6% (p  = 0.383 × 10−3)
at the 7th and 14th days, respectively (Fig. 11).
The administration of poly-MVA resulted in a non-
significant increase in the Bingham viscosity at the 1st
day (p  = 0.073), which became a significant decrease
of 18% (p  = 0.039 and 0.033) at the 7th and 14th days
(Fig. 9). The yield stress showed a significant decrease
from the control of 3.8% (p  = 0.026) at the 1st day and
41% (p  = 0.825 × 10−6 and 0.407 ×  10−5) at both the 7th
and 14th days (Fig. 10). The aggregation index did not
show a significant change from the control (Fig. 11).The treatment with poly-MVA after irradiation
resulted in a non-significant change in the Bingham vis-
cosity from the control (p  = 0.398, 0.124 and 0.084),
260 S.M. El-Marakby et al. / Journal of Taibah Un
Fig. 11. The aggregation index of control, treated, irradiated and
nificant increase of the catalase after 1 day of exposure
to radiation, but it decreased by the 14th day, which cantreated-irradiated groups at time intervals of 1, 7 and 14 days.
while it showed a significant increase of 9% (p  = 0.028,
0.038) at the 1st and 7th days and reached 14.7%
(p = 0.039) at the 14th day compared to the irradiated
group (Fig. 9). The yield stress exhibited a non-
significant decrease from the control at the 1st day
(p = 0.307), which became a significant decrease of
16.15% (p  = 0.727 ×  10−4) and 28.39% (p  = 0.0112) at
the 7th and 14th days, respectively (Fig. 10). Compared to
the irradiated group, the yield stress showed a significant
increase of 15.97% (p  = 0.019), 25.07% (p  = 0.034) and
85.46% (p  = 0.005) at the 1st, 7th and 14th days, respec-
tively. The aggregation index did not show a significant
change from the control (p  = 0.375, 0.167 and 0.332),
while it showed a significant increase from the irradi-
ated group of 5.65% (p  = 0.045) and 43.5% (p  = 0.001)
at the 7th and 14th days, respectively (Fig. 11).
3.6.  Morphological  analysis
The morphological changes of RBCs are shown in
Fig. 12. It shows the scanning electron micrographs
of the control, irradiated, treated with poly-MVA and
treated with irradiation groups at time intervals of 1, 7
and 14 days.
Fig. 12a shows the normal discoid shape of the control
RBCs. The exposure to gamma radiation resulted in mor-
phological changes in the RBCs’ membrane, as shown
in Fig. 12b, while positive control groups (administered
with poly-MVA only) showed a normal biconcave shape
(Fig. 12c). Administration of poly-MVA, after expo-
sure to radiation, decreased the formation of abnormal
shapes, reducing the radiation induced damage as shown
in Fig. 12d.iversity for Science 10 (2016) 251–265
4.  Discussion
4.1.  Effect  of  gamma  radiation
Exposure to an acute dose of gamma radiation results
in several effects, which can be observed at different
levels. It results in oxidative stress due to the pro-
duction of reactive oxygen species in cells as a result
of water radiolysis [33], which leads to lipid perox-
idation and oxidation of DNA and proteins, as well
as activation of pro-inflammatory factors, which have
been observed after both in vitro and in vivo exposures
[34]. Lipid peroxidation is commonly measured as a
function of malondialdehyde (MDA) concentration as
the principal and most studied product of polyunsatu-
rated fatty acid peroxidation [35]. In this study, MDA
increased significantly after exposure to an acute dose of
gamma radiation, in accordance with a previous study,
which showed that doses of 2 and 4 Gy of gamma radi-
ation resulted in an increase in MDA concentration
[36].
Biological cells are equipped with several natu-
ral enzymatic and non-enzymatic antioxidant defences
against these oxidative stresses [37]. Pre-clinical stud-
ies have shown the role of anti-oxidant mechanisms
in determining the degree of oxidative damage in irra-
diated tissues [38]. The response of these antioxidant
enzymes to ionizing radiation differs according to the
exposure dose. Catalase is an inducible enzyme that
decomposes H2O2 and is involved in the antioxidant
defence mechanisms of mammalian cells. Thus, it is
an index of increased H2O2 production [39]. The expo-
sure to gamma radiation of a certain limiting dose may
stimulate the activity of the catalase enzyme. This can
explain its high activity demonstrated in the livers of
irradiated rats compared to controls after whole body
exposure to 2 and 4 Gy of gamma radiation [36] and
after exposure to 10 Gy [40]. This idea was supported
by the direct increase in its biosynthesis 2 h after the
exposure of excised chick tissues to 0.5 and 2 Gy [41].
However, increasing the irradiation dose to 15 Gy was
shown to decrease its concentration significantly after
exposure [42], which could be attributed to the injuries
on the hydrogen bonds of its active site. The resulting
balance of the two concurrent processes determines the
cell’s ability to decompose the hydrogen peroxide and
restore or deteriorate the radiation-induced damage [41].
In this study, the exposure to 6 Gy resulted also in a sig-be explained by the start of radiation-induced damage to
the enzyme itself.
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Glutathione is a water-soluble tripeptide composed
f the amino acids glutamine, cysteine, and glycine. It
s the most abundant endo-cellular aminothiol, which
lays a key role in physiological detoxification [43]. The
iver, one of the tissues with the highest content of this
ripeptide, is the main tissue participating in glutathione
iosynthesis [44]. It is involved in the non-enzymatic
emoval of reactive oxygen species and also serves as
he hydrogen donor in glutathione peroxidase-mediated
eactions. The oxidized glutathione is either reduced irradiated, (c) treated with poly-MVA, and (d) treated with irradiation
back to glutathione via glutathione reductase-mediated
reactions or exported out of the cells. Therefore, it serves
as a measure of the total glutathione capacity of cells at
any given time in response to oxidative stress. Superox-
ide dismutase is another enzyme that is naturally present
in human cells that catalyses the conversion of super-
oxide to oxygen and hydrogen peroxide, acting as an
antioxidant during normal conditions and after radia-
tion. It is considered as the primary defensive enzyme
against oxygen derived free radical production [45]. Its
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action needs to be coupled with the glutathione detox-
ification of hydrogen peroxide to avoid the formation
of the highly reactive hydroxyl radical [46]. Thus, it is
possible that the enzymes associated with glutathione
levels are altered in response to ionizing radiation [47].
In this study, a significant decrease in the concentrations
of glutathione and superoxide dismutase was observed
from the 1st day after exposure until the 14th day. These
results are in accordance with the reported decrease in
the hepatic glutathione content following exposure to 2
and 4 Gy gamma radiation [36], as well as the decrease
in liver superoxide dismutase activity after exposure to
15 Gy [42].
Decreased tissue glutathione concentrations have
been associated with cell damage and depressed immu-
nity [48]. The exposure to low doses, such as from
0.25 Gy to 1 Gy, was shown to induce transformation
of red blood cells into echinocytes that are susceptible
to destruction and sequestration in small sinuses, thus
resulting in low circulating numbers [49]. Additionally,
the generation of free radicals during radiation expo-
sure results in destructive processes within both layers
of RBCs’ membrane lipids [50] and structural changes
in the membrane proteins, as well as a decrease in its
intramolecular dynamics [51]. Conformational change
of integral membrane proteins could lead to an expan-
sion of one leaflet of the membrane double layer relative
to the other, resulting in a shape change [52]. The scan-
ning electron micrographs showed that the exposure
to 6 Gy of gamma radiation resulted in modification
of the morphology of red blood cells, as shown in
the transformation from normal cells to echinocyte and
stomatocytes, with a significant increase in the mean cor-
puscular volume. The transformation to echinocytes and
stomatocytes is related to a decrease in the surface area to
volume ratio and the membrane permeability, which may
lead to a significant increase in the rate of cell haemolysis
and change in its behaviour.
The exposure to gamma radiation results in a decrease
in the concentration of all cellular components of the
blood. This can be due to the direct destruction of mature
circulating cells, loss of cells from circulation by haem-
orrhage, or leakage through capillary walls and reduced
cell production [53]. Additionally, the stem cells and
early progenitor cells are radiosensitive cells [54]. In
this study, acute exposure to 6 Gy of gamma radiation
showed a significant decrease in the haemoglobin con-
centration, and haematocrit decreased after exposure to
radiation until reaching 50% of the control value at the
14th day observed. These results may explain the signif-
icant decrease in the Bingham viscosity, yield stress and
aggregation index of blood, which persisted until the 14thiversity for Science 10 (2016) 251–265
day observed in this study, because the blood viscosity
is governed by the physical properties of red blood cells,
which constitute 99% of blood cellular components [55].
It is also affected by the changes in the haematocrit, mod-
ifications of the membrane skeletal proteins, and the ratio
of the RBC membrane surface area to cell volume, cell
morphology, and cytoplasmic viscosity, which influence
the deformability of RBCs. Additionally, RBC aggrega-
tion is mainly determined by plasma protein composition
and the surface properties of RBCs [56].
4.2.  Effect  of  poly-MVA
The active ingredient in poly-MVA, i.e., the palla-
dium-lipoic acid polymer, is in the liquid crystal state. It
acts as a liquid electrical transistor that transfers electri-
cal current from the cell membrane to the mitochondria,
which redistributes the electrical current throughout the
cell via the existing electrical pathways. Poly-MVA has
a large redox potential, making it a potent antioxidant
agent. It oscillates between an oxidized and reduced
form as it accepts unpaired electrons and donates them
to its enzymatic site; thus, it attracts excess electrons,
such as free radicals, and shuttles them to the mito-
chondria, hence, converting them into energy [9]. It
was shown that the oral administration of poly-MVA
to male albino rats with 0.38 mg/kg of body weight for
a period of 30 days enhanced the activities of Krebs’
cycle dehydrogenases and respiratory complexes in the
heart of aged rats. Moreover, it enhanced the activity
of catalase, manganese–superoxide dismutase, and glu-
tathione peroxidase, and the level of lipid peroxidation
was decreased significantly compared to the aged con-
trol. Additionally, because the palladium--lipoic acid
complex serves as a potent redox molecule, it may facil-
itate a chain breaking antioxidant effect in the lipid
peroxidation process [57]. In this study, the significant
decrease in lipid peroxidation in the poly-MVA treated
group can be attributed to the enhanced GSH level and
CAT activity, which implies that poly-MVA did not exert
oxidative stresses after its administration.
The interaction of poly-MVA as a polymer nano-
complex with red blood cells’ membranes may occur by
unspecific means, including diffusion, trans-membrane
channels, and electrostatic, van der Waals, hydration
forces, or adhesive interactions [58]. It was shown that
there was a significant increase in the relative permit-
tivity and total dipole moment of RBC membranes after
poly-MVA administration [59]. Because the increase in
the membrane surface charge increases the repulsive
force between neighbouring cells and between the cells
and vessels’ wall, facilitating their flow, it results in a
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ecrease in blood viscosity and yield stress, with a non-
ignificant change in aggregation index observed in this
tudy. Additionally, the interaction of poly-MVA with
ell membranes could result in an increase in membrane
lasticity, which explains the increase in membrane
smotic fragility and decrease in viscosity and haemat-
crit observed at the 14th day of administration.
.3.  Radio-mitigation  effect  of  poly-MVA
The effect of poly-MVA as a radioprotector can
e regarded as a result of both its radical scaveng-
ng and inducing energy production. Its oxygen radical
bsorbance capacity (ORAC) value is 5.65 [60], i.e., it
s an approximately five times more potent antioxidant
han -lipoic acid. It was demonstrated that this formula-
ion serves as both a highly active free radical scavenger
nd alternative energy source to brain cells [9]. Due to its
ntioxidant effect, it acts as a therapy of diseases associ-
ted with oxidative stress, either directly as a free radical
cavenger or indirectly due to its synergistic action with
ther antioxidants [18].
The study of its mitigating effect, by its administration
fter irradiation for two consecutive weeks, was shown
o alleviate the radiation-induced damage in the consid-
red parameters. This appeared in the normal results
f the mean corpuscular volume and mean corpuscu-
ar haemoglobin concentration and no changes in the
ercentage of haemolysis. Mitigators of radiation injury
ay target the pathways of radiation injuries to prevent
r reduce the expression of toxicity [61]. The radiation
njuries can be direct, such as targeting DNA molecules,
r indirect by the production of free radicals. As a free
adicals scavenger, it can spare an endogenous antioxi-
ant enzyme system and improve the protection against
adiation-induced damage, as seen in the normal concen-
ration of GSH and increase in the concentration of SOD
eported in this study. This shows the efficiency of the
hysiological effect of poly-MVA in mitigating the radi-
tion damage induced immediately after exposure, as it
cts as antioxidant and adaptive agent. However, some of
he studied parameters showed significant changes from
ontrol after the post-irradiation treatment with poly-
VA, such as the decrease in yield stress and dispersion
f haemolysis, haematocrit and haemoglobin concentra-
ion, which may need further investigations.
One more worthy observation in this study is that
lthough the 6 Gy single dose of gamma radiation is
onsidered to be a sub-lethal dose and is known to sig-
ificantly affect the digestive system, the oral uptake of
oly-MVA showed positive results in minimizing the
adiation-induced damage, reflecting the efficiency of
[versity for Science 10 (2016) 251–265 263
poly-MVA as a radio-mitigating agent and providing an
easy mode of administration.
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